1
|
Basso L, Chacun D, Sy K, Grosgogeat B, Gritsch K. Periodontal Diseases and COVID-19: A Scoping Review. Eur J Dent 2021; 15:768-775. [PMID: 34500484 PMCID: PMC8630939 DOI: 10.1055/s-0041-1729139] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
The aim of this scoping review was to present the existing literature regarding the relationship between periodontal diseases and coronavirus disease 2019 (COVID-19). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping review guidelines was followed. Articles were retrieved from PubMed/MEDLINE and Scopus databases and screened to include studies relating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 to periodontal cells and/or tissues and/or diseases. Twenty-five papers were included; consisting of six reviews, seven original articles, six short reports, four letters to the editor, one commentary, and one case report. The articles were allocated to three different topics: (i) hypotheses on the relationship between periodontal diseases and COVID-19; (ii) risk factors and comorbidities common to periodontitis and COVID-19; (iii) periodontal manifestations of COVID-19. Certain molecules (angiotensin-converting enzyme-2, furin, cathepsin, TMPRSS2...) that are found at a high level in periodontal tissues, particularly in patients with periodontitis, are involved in the mechanism of entry of SARS-CoV-2 into cells. Periodontopathic bacteria could also play a direct role in the mechanism of entry of SARS-CoV-2 by cleaving the S-protein, and the cytokines produced during periodontitis could add to the cytokine storm found in the severe forms of COVID-19. It thus appears that the treatment of periodontitis, which allows a reduction in periodontopathic bacteria and of the local and systemic inflammation state, could be part of a strategy to prevent the development of severe forms of COVID-19.
Collapse
Affiliation(s)
- Lisa Basso
- Univ Lyon, Université Claude Bernard Lyon 1, Laboratoire des Multimatériaux et Interfaces (UMR CNRS 5615), Villeurbanne, France
| | - Doriane Chacun
- Univ Lyon, Université Claude Bernard Lyon 1, Laboratoire des Multimatériaux et Interfaces (UMR CNRS 5615), Villeurbanne, France.,Univ Lyon, Université Claude Bernard Lyon 1, Faculté d'Odontologie, Lyon, France.,Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Unité Fonctionnelle de Parodontologie, Lyon, France
| | - Kadiatou Sy
- Univ Lyon, Université Claude Bernard Lyon 1, Faculté d'Odontologie, Lyon, France.,Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Unité Fonctionnelle de Parodontologie, Lyon, France.,Univ Lille, INSERM, U1008 - Controlled Drug Delivery Systems and Biomaterials, Lille, France
| | - Brigitte Grosgogeat
- Univ Lyon, Université Claude Bernard Lyon 1, Laboratoire des Multimatériaux et Interfaces (UMR CNRS 5615), Villeurbanne, France.,Univ Lyon, Université Claude Bernard Lyon 1, Faculté d'Odontologie, Lyon, France.,Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Unité de Recherche Clinique, Lyon, France
| | - Kerstin Gritsch
- Univ Lyon, Université Claude Bernard Lyon 1, Laboratoire des Multimatériaux et Interfaces (UMR CNRS 5615), Villeurbanne, France.,Univ Lyon, Université Claude Bernard Lyon 1, Faculté d'Odontologie, Lyon, France.,Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Unité Fonctionnelle de Parodontologie, Lyon, France
| |
Collapse
|